
Scientist/CEO @HAYA_lncRNA (https://xitter.cf/t.co/x9N85dFuqJ) Interested in the dark side of your genome and the RNAs produced by it #lncRNA
Lausanne, Switzerland
Joined February 2011
- Tweets6.1K
- Following2.8K
- Followers1.1K
- Likes3.5K
Samir Ounzain retweeted
ليل الجزائر العاصمة تحول إلى نهارٍ أمس، في مشهد جنوني لا يحدث إلا عندنا.
جماهير مولودية الجزائر صنعت لوحات استثنائية وهي تحتفل بالتتويج العاشر بلقب الدوري، فتلونت السماء بالشماريخ وغصت الشوارع والأحياء بالألوان والأهازيج والأفراح التي امتدت حتى ساعات الصباح.
فيديو خيالي يجسد عشقا لا حدود له، ويؤكد مرة أخرى أن كرة القدم في الجزائر ليست مجرد لعبة، بل شغف يعيشه الناس بكل جوارحهم.
Samir Ounzain retweeted
🚀#HAYATherapeutics has been recognized by #IDEAPharma as a #DisruptivePioneer!
This is a validation of our core mission: to advance investigational, precision #RNAguidedTherapies with the potential to tackle the actual root drivers of common and #ChronicDiseases.
Samir Ounzain retweeted
➡️hayatx.com/haya-therapeutics…
A huge thank you to our team and everyone who helped us reach this important #milestone!
Samir Ounzain retweeted
Attending #cshlregRNA next week? 🇺🇸
#HAYA’s Senior Director of Biology and Functional Genomics, Rudi Micheletti, will present our lead program, with an emphasis on the #MoA and precision #ASO targeting of #WISPER, the master lncRNA driving #MyocardialFibrosis.
Let’s connect! 🤝
Samir Ounzain retweeted
By targeting this #lncRNA, we are reprogramming the #TME and offering a novel strategy to overcome treatment resistance in solid cancers.
Let’s connect in San Diego and discuss how we can drive this wave of #precision #innovation #together!🤝
Samir Ounzain retweeted
Big news! #HAYA’s CEO @ispiyou has been named one of the @Citeline's #InVivo #RisingLeaders2026🏆
Congratulations, Samir! Your bold thinking and commitment to translating #CausalBiology into real-world impact drive the culture of #innovation at HAYA.
➡️ insights.citeline.com/in-viv…
Samir Ounzain retweeted
HTX-001 is designed to address #CardiacFibrosis by #reprogramming cardiac myofibroblasts back to a healthy state, offering a potential #NovelTherapeuticOption for patients living with #HCM. 🫀
See you in Toronto!
Samir Ounzain retweeted
✈️ Heading to the #PharmaPartneringSummitUS?
Connect with #HAYA CBO @drrichjlaw to explore our unique platform and next-gen #RNATherapies pipeline in: 🫀 Cardiovascular 🫁 Pulmonary 🔬 Oncology
Let's shape a new frontier in medicine #together. 🤝
Samir Ounzain retweeted
Join us at the panel discussions!
➡️ Learn more at: swissbiotechday.ch/program-2…
See you in Basel!
Samir Ounzain retweeted
#HAYA is heading to #SwissBiotechDay! 🇨🇭
Connect with our CEO @ispiyou and COO Eric Adam to learn more about HAYA’s unique approach and how targeting the #RegulatoryGenome holds the potential to deliver a more #precise, #durable, and #biologicallyGrounded #therapeutic strategy.
Samir Ounzain retweeted
Brilliant podcast with Samir Ounzain as he shares his journey & what led to the founding of HAYA Therapeutics; a biotech trailblazing an entirely new approach to treating common & chronic diseases by cell reprogramming via the regulatory genome. 🧬❤️🫁podbean.com/media/share/pb-y…
Samir Ounzain retweeted
Super excited that we get to take this next step in the future of Haya Therapeutics! 🧬 🚀
🚀 We're thrilled to announce that #HAYATherapeutics have successfully raised $65Million in #SeriesA round of financing 🎉
A huge #THANKYOU to our TEAM, PARTNERS, and INVESTORS! 🙌
➡️hayatx.com/news
@SofinnovaVC @EarlybirdVC
Samir Ounzain retweeted
🚀 We're thrilled to announce that #HAYATherapeutics have successfully raised $65Million in #SeriesA round of financing 🎉
A huge #THANKYOU to our TEAM, PARTNERS, and INVESTORS! 🙌
➡️hayatx.com/news
@SofinnovaVC @EarlybirdVC
Samir Ounzain retweeted
I’m really thrilled to join up with Samir and the team at HAYA Therapeutics as their new Chief Business Officer!
📣 Today, we are thrilled to welcome @drrichjlaw
as #HAYATherapeutics’ #CBO!
Looking forward to the future ahead of us. Stay tuned for more exciting news!
lnkd.in/eMVFw_8E
Welcome to the team Richard!🎉
Thrilled to welcome Rich as our new Chief Business Officer! Rich has a stellar track record in biopharma partnerships, strategic growth, and innovation and his expertise at the intersection of biology and technology has helped reshape drug discovery!
Samir Ounzain retweeted
📣 Today, we are thrilled to welcome @drrichjlaw
as #HAYATherapeutics’ #CBO!
Looking forward to the future ahead of us. Stay tuned for more exciting news!
lnkd.in/eMVFw_8E
Welcome to the team Richard!🎉
Samir Ounzain retweeted
This week, our podcast guest is Samir Ounzain, CEO of Haya Therapeutics. Ounzain was one of the first researchers to publish on lncRNA, also known as the ‘dark genome.’ labiotech.eu/podcast/targeti…
Samir Ounzain retweeted
👇🤯For everybody interested in #lncRNAs, the latest @GencodeGenes capture effort and resulting improved annotations are big news! Major increases in overall counts in human and mouse, better overlap with other collections and far higher human-mouse orthology rates
The latest preprint from GENCODE focuses on expanding and unifying lncRNA annotations. GENCODE: massively expanding the lncRNA catalog through capture long-read RNA sequencing biorxiv.org/content/10.1101/… @_Rory_Johnson_ @GOLDLab_UCD @GuigoLab @RodericGuigo @GencodeGenes














